Benjamin F. Edwards & Company’s Veradigm Inc. Common Stock MDRX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,475	Closed	-$15K	–	2292
2023 Q4	$15K	Hold	1,475	–	–	﹤0.01%	1563
2023 Q3	$19K	Hold	1,475	–	–	﹤0.01%	1273
2023 Q2	$19K	Hold	1,475	–	–	﹤0.01%	1298
2023 Q1	$19K	Hold	1,475	–	–	﹤0.01%	1288
2022 Q4	$26K	Sell	1,475 -875	-37%	-$14.7K	﹤0.01%	1227
2022 Q3	$36K	Hold	2,350	–	–	﹤0.01%	1134
2022 Q2	$35K	Hold	2,350	–	–	﹤0.01%	1127
2022 Q1	$53K	Hold	2,350	–	–	﹤0.01%	1019
2021 Q4	$43K	Hold	2,350	–	–	﹤0.01%	1085
2021 Q3	$31K	Buy	+2,350	New	+$37.9K	﹤0.01%	1138
2014 Q2	–	Sell	-500	Closed	-$9K	–	951
2014 Q1	$9K	Buy	+500	New	+$8.65K	﹤0.01%	710

Other funds holding MDRX

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Benjamin F. Edwards & Company's MDRX Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 1,475 shares — an estimated $15K sold.

Benjamin F. Edwards & Company first reported a position in MDRX in Q1 2014 and held it in 11 quarters. The position peaked at $53K in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

Benjamin F. Edwards & Company reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Benjamin F. Edwards & Company sold 1,475 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $15K.
Benjamin F. Edwards & Company first reported a position in Veradigm Inc. Common Stock in Q1 2014 and held it in 11 quarters.
Benjamin F. Edwards & Company's Veradigm Inc. Common Stock position peaked at $53K in Q1 2022.
35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.